# Phase 1 anemia trials recruiting: 37 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 37 trials in phase 1 for anemia that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 anemia trials: 37 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/anemia

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 37
- Recruiting or not yet: 37
- Read on: November 19, 2026

## Trials

The 25 newest of 37, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 28, 2026 | NCT07901959 | Safety and Tolerability of Metformin and Naproxen for Cancer Prevention in Fanconi Anemia | Rockefeller University | Phase 1 | Recruiting | Fanconi Anemia, Head and Neck Cancer, Squamous Cell Carcinoma, Squamous Cell Cancer of Head and Neck (SCCHN) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901959) |
| October 28, 2026 | NCT07901933 | Study of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease | Cajal Therapeutics Inc. | Phase 1 | Not yet recruiting | Chronic Kidney Disease, Anemia | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901933) |
| September 11, 2026 | NCT07816341 | F182112 in Relapsed/Refractory Autoimmune Hemolytic Anemia | Institute of Hematology & Blood Diseases Hospital, China | Phase 1 | Recruiting | Autoimmune Hemolytic Anemia | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816341) |
| September 2, 2026 | NCT07799571 | Buprenorphine for the Management of Pain in Children With Sickle Cell Disease | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | Sickle Cell Disease (SCD), Sickle Cell Disease Vaso-occlusive Crisis, Sickle Cell Anemia Crisis, Sickle Cell Anemia in... | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07799571) |
| August 27, 2026 | NCT07790562 | A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting Conditions | Sichuan Huiyu Pharmaceutical Co., Ltd | Phase 1 | Recruiting | Iron Deficiency Anemia | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07790562) |
| August 5, 2026 | NCT07748533 | HY001N for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. | Juventas Cell Therapy Ltd. | Phase 1 | Recruiting | Autoimmune Hemolytic Anemia (AIHA) | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07748533) |
| July 16, 2026 | NCT07708350 | Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell Disease | Sponsor not shown (see the record) | Phase 1 | Recruiting | Sickle Cell Disease, Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07708350) |
| May 28, 2026 | NCT07612345 | High-Dose Vitamin C in G6PDA and Pyruvate Kinase Deficiency: A Safety Study | University of Utah | Phase 1 | Not yet recruiting | Pyruvate Kinase Deficiency, Glucose 6 Phosphate Dehydrogenase Deficiency | 3 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07612345) |
| May 13, 2026 | NCT07585071 | IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia | Institute of Hematology & Blood Diseases Hospital, China | Phase 1 | Not yet recruiting | Autoimmune Hemolytic Anemia, Relapsed/Refractory | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07585071) |
| May 7, 2026 | NCT07574073 | CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | Anti-CD20 Monoclonal Antibody, BTK Inhibitors, Immune Thrombocytopenia (ITP), Autoimmune Hemolytic Anemia (AIHA) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07574073) |
| May 5, 2026 | NCT07566494 | Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease | National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 | Recruiting | Sickle Cell Disease, Hemolytic Anemia | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07566494) |
| March 17, 2026 | NCT07476183 | Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan... | Apriligen, Inc. | Phase 1 | Recruiting | RPS19 Deficient Diamond-Blackfan Anemia | 4 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07476183) |
| March 6, 2026 | NCT07453836 | Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia | China Immunotech (Beijing) Biotechnology Co., Ltd. | Phase 1 | Not yet recruiting | Autoimmune Hemolytic Anemia | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07453836) |
| January 30, 2026 | NCT07379125 | Therapeutic RSK1 Targeting in Myeloid Malignancies | Washington University School of Medicine | Phase 1 | Recruiting | Myeloid Malignancy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07379125) |
| January 16, 2026 | NCT07347171 | A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies | Cullgen (Shanghai),Inc | Phase 1 | Recruiting | Leukemia, AML, MDS, AML (Acute Myelogenous Leukemia), MDS (Myelodysplastic Syndrome) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07347171) |
| January 7, 2026 | NCT07321626 | Romiplostim N01 for Platelet Recovery After Haploidentical HSCT | First Affiliated Hospital of Zhejiang University | Phase 1 | Recruiting | Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Delayed Platelet Engraftment, HSCT | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07321626) |
| December 17, 2025 | NCT07287930 | A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 1 | Not yet recruiting | Autoimmune Hemolytic Anemia | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07287930) |
| November 10, 2025 | NCT07226219 | Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease | St. Jude Children's Research Hospital | Phase 1 | Recruiting | Sickle Cell Disease, Executive Dysfunction, Cognitive Impairment, Attention Deficit/Hyperactivity Disorder (ADHD) | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07226219) |
| September 23, 2025 | NCT07187973 | A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD) | Disc Medicine, Inc | Phase 1 | Recruiting | Sickle Cell Disease | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07187973) |
| July 29, 2025 | NCT07091370 | Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy | Juventas Cell Therapy Ltd. | Phase 1 | Not yet recruiting | AIHA - Cold Autoimmune Hemolytic Anemia | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07091370) |
| July 24, 2025 | NCT07083960 | OM336 in Autoimmune Cytopenias | Lakefront Biotherapeutics West LLC | Phase 1 | Recruiting | AIHA - Warm Autoimmune Hemolytic Anemia, AIHA - Cold Autoimmune Hemolytic Anemia, ITP - Immune Thrombocytopenia | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07083960) |
| June 11, 2025 | NCT07015684 | 131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD) | Columbia University | Phase 1 | Recruiting | Sickling Disorder Due to Hemoglobin S | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07015684) |
| May 18, 2025 | NCT06978738 | UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases | Changzhou No.2 People's Hospital | Phase 1 | Not yet recruiting | Systemic Lupus Erythematosus, Autoimmune Hemolytic Anemia, Myasthenia Gravis, Systemic Sclerosis, ANCA-Associated... | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06978738) |
| October 23, 2024 | NCT06655662 | Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients. | Sponsor not shown (see the record) | Phase 1 | Recruiting | Β-thalassemia | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06655662) |
| October 18, 2024 | NCT06647979 | Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies | Sponsor not shown (see the record) | Phase 1 | Recruiting | Sickle Cell Disease, Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0), Beta-Thalassemia, Transfusion Dependent... | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06647979) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| St. Jude Children's Research Hospital | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| Juventas Cell Therapy Ltd. | 2 |
| EpiDestiny, Inc. | 1 |
| Sichuan Huiyu Pharmaceutical Co., Ltd | 1 |
| City of Hope Medical Center | 1 |
| Changzhou No.2 People's Hospital | 1 |
| Rockefeller University | 1 |
| Minovia Therapeutics Ltd. | 1 |
| Cajal Therapeutics Inc. | 1 |
| University Hospital, Lille | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| University of Cincinnati | 1 |
| Washington University School of Medicine | 1 |
| Disc Medicine, Inc | 1 |
| Columbia University | 1 |
| Lakefront Biotherapeutics West LLC | 1 |
| Apollo Therapeutics Ltd | 1 |
| University of Utah | 1 |
| [Ascentage Pharma Group Inc.](https://specstream.ai/data/clinical-trials/company/ascentage-pharma-group-inc) | 1 |
| Cullgen (Shanghai),Inc | 1 |
| China Immunotech (Beijing) Biotechnology Co., Ltd. | 1 |
| Apriligen, Inc. | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 18 |
| China | 10 |
| Australia | 3 |
| Israel | 1 |
| France | 1 |
| United Kingdom | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Fast food restaurants in the United States](https://specstream.ai/data/businesses/fast-food-restaurants/united-states)
- [Masonry contractors in the United States](https://specstream.ai/data/businesses/masonry-contractors/united-states)
- [Salad bars in the United States](https://specstream.ai/data/businesses/salad-bars/united-states)
- [Alternative medicine clinics in the United States](https://specstream.ai/data/businesses/alternative-medicine-clinics/united-states)
- [Contract law firms in the United States](https://specstream.ai/data/businesses/contract-law-firms/united-states)
- [Home inspectors in the United States](https://specstream.ai/data/businesses/home-inspectors/united-states)
